The Clorox Company (CLX)

The Clorox Company Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	367	183	319	871	111
Cash & Cash Equivalents	367	183	319	871	111
Cash Growth	100.55%	-42.63%	-63.38%	684.68%	-15.27%
Receivables	688	681	604	648	631
Inventory	696	755	752	454	512
Other Current Assets	77	106	154	47	51
Total Current Assets	1,828	1,725	1,829	2,020	1,305
Property, Plant & Equipment	1,691	1,676	1,634	1,394	1,034
Goodwill and Intangibles	1,964	2,442	2,493	2,471	2,503
Other Long-Term Assets	462	315	378	328	274
Total Long-Term Assets	4,117	4,433	4,505	4,193	3,811
Total Assets	5,945	6,158	6,334	6,213	5,116
Accounts Payable	1,659	1,469	1,675	1,329	1,035
Current Debt	137	315	381	64	396
Other Current Liabilities	121	0	0	25	9
Total Current Liabilities	1,917	1,784	2,056	1,418	1,440
Long-Term Debt	2,787	2,788	2,785	3,058	2,287
Other Long-Term Liabilities	853	857	901	829	830
Total Long-Term Liabilities	3,640	3,645	3,686	3,887	3,117
Total Liabilities	5,557	5,429	5,742	5,305	4,557
Total Debt	2,924	3,103	3,166	3,122	2,683
Debt Growth	-5.77%	-1.99%	1.41%	16.36%	8.05%
Retained Earnings	583	1,048	1,036	3,567	3,150
Comprehensive Income	-493	-479	-546	-640	-602
Shareholders' Equity	220	556	411	908	559
Net Cash / Debt	-2,557	-2,920	-2,847	-2,251	-2,572
Net Cash Per Share	-20.59	-23.57	-22.36	-17.63	-19.82
Working Capital	-89	-59	-227	602	-135
Book Value Per Share	1.78	4.52	3.27	7.22	4.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).